Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, helping reduce appetite and calorie intake. Clinical trials show patients using semaglutide lose significantly more weight than those on diet and exercise alone. PlexusDx prescribes compounded semaglutide injections through licensed 503A pharmacies in all 50 states, starting at $149 per month—no insurance or membership required.

How Semaglutide Injections Support Weight Loss

Semaglutide activates GLP-1 receptors in your brain, pancreas, and gut. This activation slows the rate at which food moves from your stomach into your small intestine, which extends feelings of fullness and reduces hunger signals. The medication also improves how your body handles blood sugar, reducing cravings and helping stabilize energy throughout the day.

Research published in major medical journals demonstrates that semaglutide users lose 15-22% of their starting body weight over 68 weeks. Weight loss typically becomes noticeable after 4-6 weeks of consistent use, with steady progress over several months. Individual results vary based on genetics, lifestyle, and dose—which is why PlexusDx offers genetic testing to identify your peptide pathways.

Your semaglutide dose begins low and increases gradually every 4 weeks until reaching your therapeutic dose. This gradual approach minimizes side effects while your body adapts. PlexusDx uses flat monthly pricing, so whether you're starting or optimizing your dose, your cost remains the same—your dose may go up, but your price won't.

Eligibility Requirements for Semaglutide Therapy

Most adults qualify for semaglutide if they have a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions like hypertension, type 2 diabetes, or sleep apnea. You do not need a prior diagnosis of diabetes to receive semaglutide for weight loss. PlexusDx evaluates your health history through a simple online assessment and a telehealth consultation with a licensed prescriber.

You must be willing to commit to lifestyle changes—semaglutide works best alongside consistent physical activity and a balanced diet. Patients who combine medication with behavioral changes see the greatest long-term weight loss. If you have a personal or family history of thyroid cancer or multiple endocrine neoplasia, you will not qualify, as these are absolute contraindications.

Pregnancy and breastfeeding are periods when semaglutide should not be used. If you plan to become pregnant, discuss timing with your PlexusDx provider at least two months in advance. Women of childbearing age are encouraged to use reliable contraception while on semaglutide.

How to Start Semaglutide at PlexusDx

Getting started with PlexusDx takes three simple steps: complete an online health questionnaire, schedule a brief telehealth visit with a licensed prescriber, and receive your prescription from a licensed 503A compounding pharmacy. The entire process typically takes one to two business days. PlexusDx serves all 50 states and requires no insurance—payment is straightforward monthly billing with no hidden fees.

Once approved, your semaglutide arrives at your home, along with easy-to-follow injection instructions and supplies. Most patients self-inject once weekly in the abdomen, thigh, or upper arm using a small insulin-style pen. PlexusDx provides video tutorials and live support to ensure you feel confident administering your injections from day one.

Your starting dose is 0.25 mg per week for the first four weeks. After that, your prescriber may increase the dose by 0.25 mg each week based on your tolerance and progress. This gradual escalation continues until you reach your optimal dose, typically between 1.0 and 2.4 mg per week. PlexusDx monthly pricing remains flat throughout this entire titration process—you pay one simple price regardless of where your dose stabilizes.

Side Effects and Safety Monitoring

Common side effects during the first two to four weeks include nausea, mild diarrhea, and reduced appetite. These effects usually resolve as your body adjusts. More serious but rare side effects include pancreatitis (sudden severe abdominal pain) and gallbladder issues. Your PlexusDx provider monitors you through regular check-ins to catch and address any concerns early.

All PlexusDx semaglutide is manufactured by licensed 503A compounding pharmacies under strict quality standards. Compounded medications are legally prescribed by healthcare providers when they believe personalized dosing or delivery is medically necessary. PlexusDx does not claim compounded semaglutide is FDA-approved; rather, it is prepared under FDA-regulated compounding rules to meet individual patient needs.

You should not use semaglutide if you have a personal or family history of thyroid cancer or MEN2. Dehydration and certain kidney conditions require careful monitoring. PlexusDx requires regular follow-up appointments to ensure the medication remains safe and effective for your unique health profile. HSA and FSA accounts can be used to pay for your semaglutide injections and any genetic testing.

Personalization Through Genetic Testing

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to map your genetic predispositions across 14 metabolic pathways and 49 peptides. This test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—genes that influence how effectively you respond to GLP-1 therapy. Understanding your genetic profile helps your prescriber optimize your dose and predict which medication approach will work best for you.

Genetic insights reveal whether your weight challenges stem primarily from appetite regulation, metabolic rate, fat storage, or food reward sensitivity. Someone with a GLP1R variant may experience stronger appetite suppression at lower doses, while another person with an FTO variant may benefit from a higher dose or additional support for metabolic rate. This personalization transforms semaglutide from a one-size-fits-all approach into a precision medicine strategy tailored to your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide?

Most patients notice reduced appetite within the first two weeks and measurable weight loss within 4-6 weeks. Clinical trials show an average loss of 1-2 pounds per week during the titration phase. Results accelerate once you reach your therapeutic dose, with peak weight loss occurring between weeks 12 and 20 of treatment.

What do clinical trials show about semaglutide's effectiveness?

The STEP trials demonstrated that patients taking semaglutide lost 15-22% of their starting body weight over 68 weeks, compared to 2-3% in the placebo group. These results held across diverse age, gender, and ethnic groups. Long-term follow-up data indicates that weight loss is sustained as long as treatment continues.

How much does semaglutide cost at PlexusDx, and do I need insurance?

PlexusDx compounded semaglutide injections start at $149 per month, with flat monthly pricing regardless of your dose level. No insurance is required, no membership fee applies, and HSA/FSA accounts are accepted. This straightforward pricing makes semaglutide accessible to more patients nationwide.

What are the most common side effects, and how long do they last?

Nausea and mild diarrhea are most common during weeks 1-4 but typically resolve as your body adapts. Eating smaller, slower meals and staying hydrated help minimize gastrointestinal effects. Serious side effects like pancreatitis are rare but require immediate medical attention if sudden severe abdominal pain occurs.

How can the Precision Peptide Genetic Test improve my semaglutide results?

The Precision Peptide Genetic Test identifies your genetic variants across appetite, metabolism, and fat storage pathways. This $99 test reveals whether you're a strong GLP-1 responder, helping your PlexusDx provider optimize your dose and potentially combine semaglutide with complementary approaches for faster, more sustainable weight loss.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves